Baguinda, Morsid C.

HRN: 16-49-46  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/26/2026
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
06/26/2026
07/03/2026
IV
500MG
Q8
H PYLORI, INTRA-ABDOMINAL INFECTION
Checking Initial Appropriateness 

 Indication:  Empiric    Type of Infection:  Intra-abdominal    Compliance to guidelines: Compliant To Guidelines